MedPath

The effect of melatonin or ramelteon for patients with circadian rhythm sleep disorder.

Phase 3
Recruiting
Conditions
circadian rhythm sleep disorder
Registration Number
JPRN-UMIN000005744
Lead Sponsor
ational Center Hospital, National Center of Neurology and Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with active co-morbidities including severe conditions. Heart failure, liver failure, renal failure, severe infection. Pregnancy, breast feeding and suspected pregnancy. Under treatment of Fluvoxamine Maleate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath